Article
Cardiovascular medicine has provided a road map that ophthalmology can follow in risk assessment.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
New company OpZira formed following Alcon’s acquisition of LumiThera
NK Insights: An Interactive Corneal Sensitivity Testing Workshop
Q&A: Inside Northwestern University’s “Dinner with the Experts” educational series with Robert S. Feder, MD
3 Things You Should Know About Interventional Glaucoma Comanagement
Q&A: AEVR's executive director on #SeeWhatMatters and safeguarding the National Eye Institute
From firsts to the future: A pioneer's perspective on ophthalmology